EMA starts safety referral for prostate cancer drug
The European Medicines Agency ’s Pharmacovigilance Risk Assessment Committee has begun two new safety-related referrals
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research
More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | European Medicines Agency (EMA) | Prostate Cancer